Contract 75F40119C10096
Akina, Inc. · Department Of Health And Human Services · September 13, 2021
Akina, Inc. was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on September 13, 2021 for $264,000 of work in pharmaceutical preparation manufacturing. Performance is in West Lafayette, IN. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $992,000.
Contract details
- PIID
- 75F40119C10096
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- R&D- Medical: Other (Basic Research)
- Place of performance
- West Lafayette, IN
- First action
- September 13, 2021
Description
BAA PMQWP#187 "NEW ANALYTICAL METHODS FOR COMPLEX SAMENESS OF INJECTABLE, LONG-ACTING PLGA FORMULATIONS"
Modification timeline
-
September 13, 2021Mod P00001 · Exercise An Option$992.3K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Merck Sharp & Dohme Llc | Department Of Health And Human Services | March 27, 2026 | $361.34M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75F40119C10096?
Contract 75F40119C10096 is a federal contract awarded to Akina, Inc. by Department Of Health And Human Services on September 13, 2021 for $264,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75F40119C10096?
Akina, Inc. won contract 75F40119C10096 from Department Of Health And Human Services.
How much is contract 75F40119C10096 worth?
Contract 75F40119C10096 has obligated $264,000 to date, with a total potential value of $992,000 if all options are exercised.